$EQBK
Equity Bancshares Inc Stock $eqbk

$eqbk Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000156459020034967 Filed on July 30, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$37.93M	$44.76M
YoY Change	-15.26%	15.28%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.900M	$1.600M
YoY Change	18.75%	14.29%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$5.042M	$13.48M
YoY Change	-62.59%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$2.186M	$11.74M
YoY Change	-81.38%	33.63%
Income Tax	$497.0K	$2.510M
% Of Pretax Income	22.74%	21.38%
Net Earnings	$1.689M	$9.232M
YoY Change	-81.7%	34.44%
Net Earnings / Revenue	4.45%	20.62%
Basic Earnings Per Share	$0.11	$0.59
Diluted Earnings Per Share	$0.11	$0.58
COMMON SHARES
Basic Shares Outstanding	15.21M	15.72M
Diluted Shares Outstanding	15.30M	15.92M

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$178.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$90.90M	$84.94M
YoY Change	7.01%	15.88%
Goodwill		$136.4M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$4.205B	$4.180B
YoY Change	0.6%	12.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.60M	$13.30M
YoY Change	54.89%	25.47%
Accrued Expenses		$3.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$51.60M	$41.00M
YoY Change	25.85%	-0.97%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$20.60M	$16.50M
YoY Change	24.85%	55.66%
LONG-TERM LIABILITIES
Long-Term Debt	$55.60M	$29.70M
YoY Change	87.21%	-8.62%
Other Long-Term Liabilities	$5.600M	$3.700M
YoY Change	51.35%	117.65%
Total Long-Term Liabilities	$61.20M	$33.40M
YoY Change	83.23%	-2.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.60M	$16.50M
Total Long-Term Liabilities	$61.20M	$33.40M
Total Liabilities	$3.726B	$3.722B
YoY Change	0.1%	13.5%
SHAREHOLDERS EQUITY
Retained Earnings	$128.7M	$105.3M
YoY Change	22.18%
Common Stock	$385.1M	$381.3M
YoY Change	1.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$37.41M	$26.86M
YoY Change	39.28%
Treasury Stock Shares
Shareholders Equity	$479.8M	$458.4M
YoY Change
Total Liabilities & Shareholders Equity	$4.205B	$4.180B
YoY Change	0.6%	12.6%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	$1.689M	$9.232M
YoY Change	-81.7%	34.44%
Depreciation, Depletion And Amortization	$1.900M	$1.600M
YoY Change	18.75%	14.29%
Cash From Operating Activities	$16.10M	$6.100M
YoY Change	163.93%	12.96%
INVESTING ACTIVITIES
Capital Expenditures	-$3.200M	-$4.300M
YoY Change	-25.58%	258.33%
Acquisitions
YoY Change
Other Investing Activities	-$234.0M	-$89.90M
YoY Change	160.29%	-7.03%
Cash From Investing Activities	-$237.2M	-$94.20M
YoY Change	151.8%	-3.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	257.2M	102.1M
YoY Change	151.91%	5.26%
NET CHANGE
Cash From Operating Activities	16.10M	6.100M
Cash From Investing Activities	-237.2M	-94.20M
Cash From Financing Activities	257.2M	102.1M
Net Change In Cash	36.10M	14.00M
YoY Change	157.86%	211.11%
FREE CASH FLOW
Cash From Operating Activities	$16.10M	$6.100M
Capital Expenditures	-$3.200M	-$4.300M
Free Cash Flow	$19.30M	$10.40M
YoY Change	85.58%	57.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	689206000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34078000
CY2020Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y4M24D
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y
CY2020Q2	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	4017000
CY2020Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	37933000
CY2020Q2	us-gaap	Contractual Obligation ContractualObligation	5571000
CY2020Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	20633000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	479766000
CY2020Q2	us-gaap	Subordinated Debt SubordinatedDebt	55575000
CY2020Q2	us-gaap	Liabilities Liabilities	3725503000
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	174000
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	384955000
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	128704000
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3390000
CY2020Q2	eqbk	Loans Receivable To Purchase Of Common Stock For Terminating Employee Restricted Stock LoansReceivableToPurchaseOfCommonStockForTerminatingEmployeeRestrictedStock	43000
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	37414000
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4205269000
CY2020Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	32627000
CY2020Q2	us-gaap	Interest Income Federal Funds Sold And Securities Purchased Under Agreements To Resell InterestIncomeFederalFundsSoldAndSecuritiesPurchasedUnderAgreementsToResell	409000
CY2019Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	12996000
CY2019Q2	eqbk	Employee Stock Loans Repayments Value EmployeeStockLoansRepaymentsValue	4000
CY2019Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7208000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	478060000
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2556652000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12232000
CY2019Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2544420000
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	623000
CY2020Q2	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	880000
CY2020Q2	eqbk	Interest Expense Federal Reserve Bank Discount Window InterestExpenseFederalReserveBankDiscountWindow	6000
	eqbk	Interest Expense Federal Reserve Bank Discount Window InterestExpenseFederalReserveBankDiscountWindow	6000
	us-gaap	Interest Expense Other Long Term Debt InterestExpenseOtherLongTermDebt	309000
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	644000
	us-gaap	Interest Expense InterestExpense	26039000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	61927000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	16620000
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	45307000
	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	987000
	us-gaap	Gain Loss On Investments GainLossOnInvestments	13000
	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	1809000
	us-gaap	Noninterest Income NoninterestIncome	11775000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	27165000
	us-gaap	Occupancy Net OccupancyNet	4155000
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	4763000
	us-gaap	Professional Fees ProfessionalFees	2384000
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1368000
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15918274
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15449517
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Communication Communication	1070000
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1008000
	us-gaap	Postage Expense PostageExpense	668000
	eqbk	Free Nationwide Atm Cost FreeNationwideATMCost	781000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1564000
	us-gaap	Loan Processing Fee LoanProcessingFee	443000
	us-gaap	Other Revenue Expense From Real Estate Operations OtherRevenueExpenseFromRealEstateOperations	-414000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	9232000
CY2019Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1476000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	998000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	458406000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	477351000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	1689000
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-379000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1102000
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	455941000
	us-gaap	Net Income Loss NetIncomeLoss	5159000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3576000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1732000
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	316000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	458406000
	us-gaap	Net Income Loss NetIncomeLoss	2947000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3393000
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	354000
	eqbk	Employee Stock Loans Repayments Value EmployeeStockLoansRepaymentsValue	34000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	479766000
	us-gaap	Net Income Loss NetIncomeLoss	5159000
	us-gaap	Share Based Compensation ShareBasedCompensation	1732000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1743000
	eqbk	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	306000
	eqbk	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	305000
	eqbk	Amortization Of Cloud Computing Implementation Costs AmortizationOfCloudComputingImplementationCosts	46000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	22440000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	16620000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	2738000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2677000
	eqbk	Amortization Of Intangibles AmortizationOfIntangibles	1588000
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-15000
	eqbk	Increase Decrease In Federal Home Loan Bank Stock Dividends IncreaseDecreaseInFederalHomeLoanBankStockDividends	-421000
	eqbk	Gain Loss On Sales And Valuation Adjustments On Other Real Estate Owned GainLossOnSalesAndValuationAdjustmentsOnOtherRealEstateOwned	-49000
	eqbk	Gain Loss On Foreclosed Assets GainLossOnForeclosedAssets	-48000
	eqbk	Gain Loss On Foreclosed Assets GainLossOnForeclosedAssets	-20000
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1155000
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	708000
	eqbk	Originations Of Loans Held For Sale OriginationsOfLoansHeldForSale	55131000
	eqbk	Originations Of Loans Held For Sale OriginationsOfLoansHeldForSale	37324000
	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	56992000
	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	34243000
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	963000
	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	987000
	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	-488000
	us-gaap	Increase Decrease In Derivative Assets IncreaseDecreaseInDerivativeAssets	4038000
	us-gaap	Operating Lease Payments OperatingLeasePayments	360000
	us-gaap	Operating Lease Payments OperatingLeasePayments	401000
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	3860000
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-686000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5688000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-638000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	948000
	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	85000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24646000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18936000
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	57868000
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	2754000
	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	71028000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	25818000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	11241000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	107423000
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	49718000
	us-gaap	Proceeds From Payments For In Interest Bearing Deposits In Banks ProceedsFromPaymentsForInInterestBearingDepositsInBanks	250000
	eqbk	Payments To Acquire Other Real Estate1 PaymentsToAcquireOtherRealEstate1	62000
	eqbk	Payments To Acquire Other Real Estate1 PaymentsToAcquireOtherRealEstate1	8000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4431000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5587000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	17000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10000
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	219000
	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	169000
	eqbk	Payments For Proceeds From Federal Home Loan Bank Stock And Federal Reserve Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStockAndFederalReserveBankStock	260000
	eqbk	Payments For Proceeds From Federal Home Loan Bank Stock And Federal Reserve Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStockAndFederalReserveBankStock	3591000
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	2706000
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	1051000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-180840000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37831000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	183694000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-36199000
	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	15849000
	us-gaap	Proceeds From Payments For In Securities Sold Under Agreements To Repurchase ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase	-9021000
	eqbk	Proceeds From Repayments Of Federal Home Loan Bank Borrowings ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings	-231223000
	eqbk	Proceeds From Repayments Of Federal Home Loan Bank Borrowings ProceedsFromRepaymentsOfFederalHomeLoanBankBorrowings	61155000
	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	253000000
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	1240000
	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	1223000
	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	62000000
	eqbk	Principal Payments On Federal Reserve Bank Discount Window PrincipalPaymentsOnFederalReserveBankDiscountWindow	62000000
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	38354000
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	7208000
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	47344000
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	7350000
	eqbk	Principal Receivables On Employee Stock Loan PrincipalReceivablesOnEmployeeStockLoan	34000
	eqbk	Principal Receivables On Employee Stock Loan PrincipalReceivablesOnEmployeeStockLoan	38000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12000
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	316000
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	354000
	us-gaap	Proceeds From Issuance Of Subordinated Long Term Debt ProceedsFromIssuanceOfSubordinatedLongTermDebt	42000000
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1140000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6892000
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7208000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-265000
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-221000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	88999000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	89291000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	192818000
	us-gaap	Interest Paid Net InterestPaidNet	14547000
	us-gaap	Interest Paid Net InterestPaidNet	24508000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	330000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	718000
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	1845000
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	494000
	eqbk	Noncash Or Part Noncash Operating Leases Recognized NoncashOrPartNoncashOperatingLeasesRecognized	3546000
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Reclassifications</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some items in prior financial statements were reclassified to conform to the current presentation. Management determined the items reclassified are immaterial to the consolidated financial statements taken as a whole and did not result in a change in equity or net income for the periods reported.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Risk and Uncertainties</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The outbreak of COVID-19 has adversely impacted a broad range of industries in which the Company’s customers operate and could impair their ability to fulfill their financial obligations to the Company. The World Health Organization has declared COVID-19 to be a global pandemic indicating that almost all public commerce and related business activities must be, to varying degrees, curtailed with the goal of decreasing the rate of new infections. The spread of the outbreak has caused significant disruptions in the U.S. economy and has disrupted banking and other financial activity in the areas in which the Company operates. While there has been no material impact to the Company’s employees to date, COVID-19 could also potentially create widespread business continuity issues for the Company.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Congress, the President, and the Federal Reserve have taken several actions designed to cushion the economic fallout. Most notably, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was signed into law at the end of March 2020 as a $2 trillion legislative package. The goal of the CARES Act is to prevent a severe economic downturn through various measures, including direct financial aid to American families and economic stimulus to significantly impacted industry sectors. The package also includes extensive emergency funding for hospitals and medical providers. In addition to the general impact of COVID-19, certain provisions of the CARES Act as well as other recent legislative and regulatory relief efforts are expected to have a material impact on the Company’s operations.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s business is dependent upon the willingness and ability of its employees and customers to conduct banking and other financial transactions. If the global response to contain COVID-19 is unsuccessful, the Company could experience a material adverse effect on its business, financial condition, results of operations and cash flows. While it is not possible to know the full universe or extent that the impact of COVID-19, and resulting measures to curtail its spread, will have on the Company’s operations, the Company is disclosing potentially material items of which it is aware.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Financial position and results of operations</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s interest income and fees could be reduced due to COVID-19. In keeping with guidance from regulators, the Company is actively working with COVID-19 affected borrowers to defer their payments, interest, and fees. While interest and fees will still accrue to income, through normal GAAP accounting, should eventual credit losses on these deferred payments emerge, interest income and fees accrued would need to be reversed. In such a scenario, interest income in future periods could be negatively impacted. At this time, the Company is unable to project the materiality of such an impact, but recognizes the breadth of the economic impact may affect its borrowers’ ability to repay in future periods.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Capital and liquidity</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020, all our capital ratios, and our subsidiary bank’s capital ratios, were in excess of regulatory requirements. While we are currently classified as well capitalized, an extended economic recession brought about by COVID-19 could adversely impact our reported and regulatory capital ratios by further credit losses. The Company relies on cash on hand as well as dividends from its subsidiary bank to service its debt. If the Company’s subsidiary bank’s capital deteriorates such that it is unable to pay dividends to the Company for an extended period of time, the Company may not be able to service its debt.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains access to multiple sources of liquidity. Wholesale funding markets have remained open to us, but rates for short term funding have recently been volatile. If funding costs are elevated for an extended period of time, it could have an adverse effect on the Company’s net interest margin. If an extended recession caused large numbers of the Company’s deposit customers to withdraw their funds, the Company might become more reliant on volatile or more expensive sources of funding.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Asset valuation</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Currently, the Company does not expect COVID-19 to affect its ability to account timely for the assets on its balance sheet; however, this could change in future periods. While certain valuation assumptions and judgments will change to account for pandemic-related circumstances such as widening credit spreads, the Company does not anticipate significant changes in methodology used to determine the fair value of assets measured in accordance with GAAP.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At March 31, 2020, the Company performed a qualitative analysis to assess goodwill for impairment of Equity Bancshares, Inc., the sole reporting unit and concluded that goodwill was not impaired. At June 30, 2020, the Company considered the on-going economic market disruption, the movement of the Company’s stock price in relation to other bank indexes and the length of time that the market value of the reporting unit has been below its book value as triggering events and has completed a quantitative analysis to assess whether or not goodwill was impaired. The analysis estimated fair value of the reporting unit to be $480,850 and the Company has concluded that goodwill was not impaired June 30, 2020.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The determination of the fair value of the reporting unit incorporates assumptions that marketplace participants would use in their estimates of fair value in a change in control transaction, as prescribed by ASC Topic 820. To arrive at a conclusion of fair value, we utilized both the income approach and the market approach and then applied weighting factors to each approach. Weighting factors represent our best business judgement of the weightings a market participant would utilize in arriving at fair value of the reporting unit. In performing the analysis, Company management made numerous assumptions with respect to industry performance, reporting unit business performance, economic and market conditions and various other matters, many of which require significant management judgement. Projections related to business unit performance over the next five years assumed an economic downturn over a 12-month time horizon subsequently returning to conservative positive growth rates in loan and deposits after that time period. The analysis performed and the assumptions that are incorporated into the analysis reflect the best currently available estimates and judgements as to the expected future financial performance of the reporting unit.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Further and sustained declines in the Company’s stock price, may require further quantitative and qualitative analysis and could result in an impairment charge being recorded for that period. In the event that the Company concludes that all or a portion of its goodwill is impaired, a non-cash charge for the amount of such impairment would be recorded to earnings. Such a charge would have no impact on tangible capital or regulatory capital.</p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Processes, controls and business continuity plan</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020, all the Company’s bank locations were open to customers with social distancing measures in place, allowing full access for customer use. Customers are served by appointment, calling ahead, curbside and drive through but offered full lobby access during normal hours. The Company does not anticipate incurring additional material cost related to its continued deployment of the preparedness plan and no material operational or internal control challenges or risks have been identified to date. </p> <p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company does not anticipate significant challenges to its ability to maintain its systems and controls in light of the measures the Company has taken to prevent the spread of COVID-19. The Company does not currently face any material resource constraint through the implementation of its business continuity plans.</span></p> <p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Lending operations and accommodations to borrowers</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In keeping with regulatory guidance to work with borrowers during this unprecedented situation and as outlined in the CARES Act, the Company has worked with customers directly affected by COVID-19 and offered short-term assistance in accordance with regulatory guidelines. Commercial borrowers needing assistance have been offered either a 90-day principal and interest deferral or a 180-day principal only deferral. Commercial borrowers that originally requested a 90-day deferral can request an additional 90-day deferral by providing their previous year financial information, current year interim financial information, projections for the balance of the calendar year and information related to their cash reserves to show a need for the additional 90-day deferral. Consumers needing assistance have been offered a 90-day principal and interest deferral with an option to request an additional 90-day deferral. At the end of the deferral period, the interest will be capitalized and the loan re-amortized generally causing a minimal increase to payments for most consumers. As of June 30, 2020, the Company had executed 1,296 of these deferrals on outstanding loan balances of $649,326, with interest deferred of $7,013. In accordance with interagency guidance issued in March 2020, these short-term deferrals are not automatically considered troubled debt restructurings, are not reflected in past due loan balances and have not been reported as a classified loan solely due to a deferral. These deferred loans are subject to ongoing monitoring and will be downgraded or placed on nonaccrual if a noted weakness exists.</p><p style="margin-bottom:6pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table lists loans by category that have been deferred under the payment deferral program at June 30, 2020.</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial real estate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">465,373</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial and industrial</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">137,453</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Residential real estate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agricultural real estate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,322</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consumer</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,964</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agricultural</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">285</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loans</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">649,326</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">With the passage of the Paycheck Protection Program (“PPP”), administered by the Small Business Administration (“SBA”), the Company is actively participating in assisting its customers with applications for resources through the program. PPP loans originated prior to June 5, 2020, have a <span style="-sec-ix-hidden:F_000625">two-year</span> term and originated on or after June 5, 2020, have a 5-year term, unless the lender and borrower agree differently. All PPP loans earn interest at 1%. As of June 30, 2020, there were 3,081 loans with an outstanding balance of $372,964 that were originated under the PPP program. It is the Company’s understanding that loans funded through the PPP program are fully guaranteed by the U.S. government. Should those circumstances change, the Company could be required to establish additional allowance for loan loss through additional provision for loan loss expense charged to earnings.</p><p style="margin-top:18pt;margin-bottom:0pt;margin-left:2.54%;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Credit</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has worked with customers directly affected by COVID-19 and offered short-term assistance in accordance with regulatory guidelines. Commercial borrowers needing assistance have been offered either a 90-day principal and interest deferral or a 180-day principal only deferral. Consumers needing assistance have been offered a 90-day principal and interest deferral with a potential additional 90-day deferral. At the end of the deferral period, the interest will be capitalized and the loan re-amortized generally causing a minimal increase in payments for most consumers. As a result of the current economic environment caused by the COVID-19 virus, the Company is engaging in frequent communication with borrowers to better understand their situation and the challenges faced, allowing it to respond proactively as needs and issues arise. Should economic conditions worsen, the Company could experience further increases in its required allowance for loan losses and record additional provision for loan losses. It is possible that the Company’s asset quality measures could worsen at future measurement periods if the effects of COVID-19 are prolonged.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Many industries have and will continue to experience adverse impacts as a result of the COVID-19 virus. Our exposure from outstanding loans and commitments to industries which we consider a higher risk totaled approximately $273,000 in hospitality, $206,000 in retail, $108,000 in restaurants and $63,000 in aircraft manufacturing.</p>
CY2020Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2020Q2	eqbk	Estimated Fair Value Of Assets EstimatedFairValueOfAssets	480850
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0
CY2020Q2	eqbk	Cares Act Financing Receivable Modifications Number Of Contracts CARESActFinancingReceivableModificationsNumberOfContracts	1296
CY2020Q2	eqbk	Cares Act Financing Receivable Loan Modifications CARESActFinancingReceivableLoanModifications	649326
CY2020Q2	eqbk	Cares Act Payment Deferral Program Deferred Interest CaresActPaymentDeferralProgramDeferredInterest	7013
CY2020Q2	us-gaap	Loans And Leases Receivable Net Of Deferred Income LoansAndLeasesReceivableNetOfDeferredIncome	649326000
CY2020Q2	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	245193000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7495000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11400000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	178290000
CY2020Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	172079000
CY2020Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5149000
CY2020Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	177228000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	141082000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1261000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	276000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	142067000
CY2020Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	662522000
CY2020Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	27420000
CY2020Q2	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	736000
CY2020Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	689206000
CY2019Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	769059000
CY2019Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Gain HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain	15414000
CY2019Q4	us-gaap	Held To Maturity Securities Accumulated Unrecognized Holding Loss HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss	562000
CY2019Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	783911000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	9974000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	10109000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	28001000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	28899000
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	7500000
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	7611000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount	52083000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	53351000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount	65931000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities After Ten Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue	68100000
CY2020Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	164579000
CY2020Q2	us-gaap	Mortgage Backed Securities Available For Sale Fair Value Disclosure MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure	169617000
CY2020Q2	us-gaap	Held To Maturity Securities Debt Maturities Without Single Maturity Date Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithoutSingleMaturityDateNetCarryingAmount	506533000
CY2020Q2	us-gaap	Mortgage Backed Securities Held To Maturity Fair Value Disclosure MortgageBackedSecuritiesHeldToMaturityFairValueDisclosure	528747000
CY2020Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	172079000
CY2020Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	177228000
CY2020Q2	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	662522000
CY2020Q2	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	689206000
CY2020Q2	us-gaap	Securities Held As Collateral At Fair Value SecuritiesHeldAsCollateralAtFairValue	789995000
CY2019Q4	us-gaap	Securities Held As Collateral At Fair Value SecuritiesHeldAsCollateralAtFairValue	780038000
CY2020Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	0
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2017000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	32466000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	273000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	34483000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	276000
CY2020Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	12250000
CY2020Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	716000
CY2020Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	535000
CY2020Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	21000
CY2020Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	12785000
CY2020Q2	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	737000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	28828000
CY2020Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	12500000
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	286000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34078000
CY2019Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	26340000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	69000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	99340000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	661000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Fair Value HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue	128168000
CY2019Q4	us-gaap	Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	730000
CY2020Q2	us-gaap	Held To Maturity Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions HeldToMaturitySecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions	31
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
CY2020Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2806334000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34078000
CY2020Q2	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	2772256000
CY2020Q2	eqbk	Unamortized Merger Purchase Accounting Adjustments Balance UnamortizedMergerPurchaseAccountingAdjustmentsBalance	6644000
CY2020Q2	eqbk	Loans Purchased At Discount LoansPurchasedAtDiscount	458166000
CY2019Q4	eqbk	Unamortized Merger Purchase Accounting Adjustments Balance UnamortizedMergerPurchaseAccountingAdjustmentsBalance	8287000
CY2019Q4	eqbk	Loans Purchased At Discount LoansPurchasedAtDiscount	624747000
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	21915000
CY2019Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	974000
CY2019Q2	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	9744000
CY2019Q2	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	207000
CY2019Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	17777000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12232000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	22440000
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	980000
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	386000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34078000
CY2018Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	11454000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	16620000
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	10682000
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	385000
CY2019Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	17777000
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	5421000
CY2020Q2	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	26359000
CY2020Q2	eqbk	Allowance For Loan Losses Purchased Credit Impaired Loans AllowanceForLoanLossesPurchasedCreditImpairedLoans	2298000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	34078000
CY2020Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2806334000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	935000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12232000
CY2019Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	29551000
CY2019Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	2503711000
CY2019Q4	eqbk	Financing Receivable Purchase Credit Impaired Loans FinancingReceivablePurchaseCreditImpairedLoans	23390000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2556652000
CY2020Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	24397000
CY2020Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	18182000
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	28323000
CY2019Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	22839000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	11900000
CY2019Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	10388000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1215000
CY2020Q2	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	59734000
CY2020Q2	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	48440000
CY2019Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	40223000
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	33227000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1215000
CY2020Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	1000
CY2019Q2	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	114000
CY2020Q2	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	25483000
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	11017000
CY2019Q4	eqbk	Allowance For Loan Losses Purchased Credit Impaired Loans AllowanceForLoanLossesPurchasedCreditImpairedLoans	280000
CY2019Q2	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	16000
CY2020Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	44316000
CY2020Q2	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	200000
CY2019Q2	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	57870000
CY2019Q2	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	130000
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	20168000
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	29000
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeCashBasisMethod	115000
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	20451000
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	200000
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	34876000
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Cash Basis Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeCashBasisMethod	92000
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	40619000
	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	229000
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	52764000
	us-gaap	Impaired Financing Receivable Interest Income Cash Basis Method ImpairedFinancingReceivableInterestIncomeCashBasisMethod	207000
CY2020Q2	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	2000
CY2020Q2	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	48440000
CY2020Q2	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2753661000
CY2020Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2806334000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	38379000
CY2020Q2	us-gaap	Hedged Asset Fair Value Hedge HedgedAssetFairValueHedge	5693000
CY2019Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	2514239000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2556652000
CY2020Q2	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2806334000
CY2019Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	2556652000
CY2020Q2	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	15063000
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	15508000
CY2020Q2	eqbk	Financing Receivable Tdr Allowance FinancingReceivableTDRAllowance	334000
CY2019Q4	eqbk	Financing Receivable Tdr Allowance FinancingReceivableTDRAllowance	0
CY2020Q2	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2019Q4	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2020Q2	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2019Q2	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2019	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
CY2020	us-gaap	Financing Receivable Modifications Subsequent Default Number Of Contracts1 FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1	0
	eqbk	Cares Act Financing Receivable Modifications Number Of Contracts CARESActFinancingReceivableModificationsNumberOfContracts	1296
	eqbk	Cares Act Of2020 Aid Amount CARESActOf2020AidAmount	649326000
CY2020Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	119526000
CY2020Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	8084000
CY2020Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	9550000
CY2019Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	120368000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	3535000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	4076000
CY2020Q2	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	9441000
CY2019Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	4186000
CY2020Q2	eqbk	Derivative Asset Netting Adjustment DerivativeAssetNettingAdjustment	15000
CY2020Q2	eqbk	Derivative Liability Netting Adjustment DerivativeLiabilityNettingAdjustment	15000
CY2019Q4	eqbk	Derivative Asset Netting Adjustment DerivativeAssetNettingAdjustment	182000
CY2019Q4	eqbk	Derivative Liability Netting Adjustment DerivativeLiabilityNettingAdjustment	182000
CY2020Q2	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	8099000
CY2020Q2	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	124000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral	3717000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	72000
CY2020Q2	us-gaap	Hedged Asset Fair Value Hedge Cumulative Increase Decrease HedgedAssetFairValueHedgeCumulativeIncreaseDecrease	582000
CY2020Q2	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	0
CY2019Q2	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	0
	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	0
	us-gaap	Gain Loss On Fair Value Hedge Ineffectiveness Net GainLossOnFairValueHedgeIneffectivenessNet	0
CY2020Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	8000
CY2019Q2	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-259000
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-484000
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-322000
CY2020Q2	eqbk	Gain Loss On Derivative Instruments And Hedging Activities Net Pretax GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax	8000
CY2019Q2	eqbk	Gain Loss On Derivative Instruments And Hedging Activities Net Pretax GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax	-259000
	eqbk	Gain Loss On Derivative Instruments And Hedging Activities Net Pretax GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax	-484000
	eqbk	Gain Loss On Derivative Instruments And Hedging Activities Net Pretax GainLossOnDerivativeInstrumentsAndHedgingActivitiesNetPretax	-322000
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3847000
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3811000
CY2020Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0297
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4153000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	4112000
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0295
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	183000
CY2019Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	182000
	us-gaap	Operating Lease Cost OperatingLeaseCost	365000
	us-gaap	Operating Lease Cost OperatingLeaseCost	355000
CY2020Q2	us-gaap	Variable Lease Cost VariableLeaseCost	8000
CY2019Q2	us-gaap	Variable Lease Cost VariableLeaseCost	10000
	us-gaap	Variable Lease Cost VariableLeaseCost	19000
	us-gaap	Variable Lease Cost VariableLeaseCost	23000
CY2020Q2	us-gaap	Lease Cost LeaseCost	191000
CY2019Q2	us-gaap	Lease Cost LeaseCost	192000
	us-gaap	Lease Cost LeaseCost	384000
	us-gaap	Lease Cost LeaseCost	378000
	us-gaap	Lessor Sales Type Lease Lease Not Yet Commenced Description LessorSalesTypeLeaseLeaseNotYetCommencedDescription	There were no sales and leaseback transactions, leverage leases, lease transactions with related parties or leases that had not yet commenced during the three or six-month periods ended June 30, 2020.
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	548000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	503000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	471000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	279000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	215000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2940000
CY2020Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4956000
CY2020Q2	eqbk	Lessee Operating Lease Liability Discounted Amount LesseeOperatingLeaseLiabilityDiscountedAmount	1145000
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	3811000
CY2020Q2	us-gaap	Federal Funds Purchased FederalFundsPurchased	0
CY2019Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0
CY2020Q2	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	51557000
CY2019Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	35708000
	eqbk	Securities Sold Under Agreements To Repurchase Average Balance Of Agreements Outstanding SecuritiesSoldUnderAgreementsToRepurchaseAverageBalanceOfAgreementsOutstanding	42468000
CY2019	eqbk	Securities Sold Under Agreements To Repurchase Average Balance Of Agreements Outstanding SecuritiesSoldUnderAgreementsToRepurchaseAverageBalanceOfAgreementsOutstanding	42459000
	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	53543000
CY2019	us-gaap	Line Of Credit Facility Maximum Monthend Outstanding Amount LineOfCreditFacilityMaximumMonthendOutstandingAmount	45575000
CY2020Q2	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0019
CY2019Q4	us-gaap	Short Term Debt Weighted Average Interest Rate ShortTermDebtWeightedAverageInterestRate	0.0040
CY2020Q2	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	344900000
CY2019Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	324373000
CY2017Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	30000000
CY2019Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40000000
CY2019Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2020-05-15
	eqbk	Debt Instrument Extended Date DebtInstrumentExtendedDate	2020-08-15
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2021-08-15
CY2017Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2017Q1	eqbk	Debt Instrument Floating Floor Interest Rate DebtInstrumentFloatingFloorInterestRate	0.0350
CY2017Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0020
CY2019Q4	us-gaap	Subordinated Debt SubordinatedDebt	14561000
CY2020Q2	us-gaap	Subordinated Long Term Debt SubordinatedLongTermDebt	14715000
CY2019Q4	us-gaap	Subordinated Long Term Debt SubordinatedLongTermDebt	14561000
CY2020Q2	us-gaap	Subordinated Debt SubordinatedDebt	55575000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	387234000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2357000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2357000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	2107000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1857000
CY2020Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	63120000
CY2020Q2	us-gaap	Long Term Debt LongTermDebt	459032000
CY2020Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2020Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	295461
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	23.33
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15209483
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15723311
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3390000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15298590
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15763686
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	9232000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2947000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5159000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3000
CY2020Q2	eqbk	Common Equity Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets CommonEquityTierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.065
CY2020Q2	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	8
CY2020Q2	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	10
CY2020Q2	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	5
CY2020Q2	eqbk	Capital Conservation Buffer Required For Capital Adequacy CapitalConservationBufferRequiredForCapitalAdequacy	0.025
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1689000
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9232000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2947000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5159000
CY2020Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15209388
CY2019Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15723116
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15297028
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	15761333
CY2020Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	95
CY2019Q2	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	195
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1562
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	2353
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15209483
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15723311
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15298590
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15763686
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1689000
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	23453
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	10466
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	28016
	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	16182
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15304009
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15992265
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.32
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	640850
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	512752
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	495698
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	322993
	eqbk	Fair Value Assets And Liabilities Levels Transfers Amount FairValueAssetsAndLiabilitiesLevelsTransfersAmount	0
CY2019	eqbk	Fair Value Assets And Liabilities Levels Transfers Amount FairValueAssetsAndLiabilitiesLevelsTransfersAmount	0
CY2019Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1474000
CY2019Q2	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	14500000

Files In Submission

Name	View Source	Status
0001564590-20-034967-index-headers.html	Edgar Link	pending
0001564590-20-034967-index.html	Edgar Link	pending
0001564590-20-034967.txt	Edgar Link	pending
0001564590-20-034967-xbrl.zip	Edgar Link	pending
eqbk-10q_20200630.htm	Edgar Link	pending
eqbk-10q_20200630_htm.xml	Edgar Link	completed
eqbk-20200630.xsd	Edgar Link	pending
eqbk-20200630_cal.xml	Edgar Link	unprocessable
eqbk-20200630_def.xml	Edgar Link	unprocessable
eqbk-20200630_lab.xml	Edgar Link	unprocessable
eqbk-20200630_pre.xml	Edgar Link	unprocessable
eqbk-ex311_6.htm	Edgar Link	pending
eqbk-ex312_7.htm	Edgar Link	pending
eqbk-ex321_8.htm	Edgar Link	pending
eqbk-ex322_9.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EQBK
Equity Bancshares Inc Stock $eqbk

2020 Q2 Form 10-Q Financial Statement

#000156459020034967 Filed on July 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EQBK Equity Bancshares Inc Stock $eqbk

2020 Q2 Form 10-Q Financial Statement

#000156459020034967 Filed on July 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EQBK
Equity Bancshares Inc Stock $eqbk